[CrossRef] [PubMed] 104. Chae, Y.K.; Viveiros, P .; Lopes, G.; Sukhadia, B.; Sheikh, M.M.; Saravia, D.; Florou, V .; Sokol, E.S.; Frampton, G.M.; Chalmers, Z.R.; et al. Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer. J. Thorac. Oncol. 2019 ,14, 1807–1817. [CrossRef] [PubMed] 105. Miller, A.; Asmann, Y.; Cattaneo, L.; Braggio, E.; Keats, J.; Auclair, D.; Lonial, S.; MMRF CoMMpass Network; Russell, S.J.; Stewart, A.K. High Somatic Mutation and Neoantigen Burden Are Correlated with Decreased Progression-Free Survival in Multiple Myeloma. Blood Cancer J. 2017 ,7, e612. [CrossRef] [PubMed] 106. Yarchoan, M.; Johnson, B.A.; Lutz, E.R.; Laheru, D.A.; Jaffee, E.M. Targeting Neoantigens to Augment Antitumour Immunity. Nat. Rev. Cancer 2017 ,17, 209–222. [CrossRef] [PubMed] 107. Yin, D.; Zhou, T.; Xia, X.; Han, C.; Liu, Z.; Li, Q.; Shu, Y.; Xu, H. Novel Insights into HBV-hepatocellular Carcinoma at Single-cell Sequencing. MedComm Oncol. 2023 ,2, e60. [CrossRef] 108. Carreno, B.M.; Magrini, V .; Becker-Hapak, M.; Kaabinejadian, S.; Hundal, J.; Petti, A.A.; Ly, A.; Lie, W.-R.; Hildebrand, W.H.; Mardis, E.R.; et al. Cancer Immunotherapy. A Dendritic Cell Vaccine Increases the Breadth and Diversity of Melanoma Neoantigen-Specific T Cells. Science 2015 ,348, 803–808. [CrossRef] [PubMed] Vaccines 2024 ,12, 717 22 of 24 109. Cafri, G.; Gartner, J.J.; Zaks, T.; Hopson, K.; Levin, N.; Paria, B.C.; Parkhurst, M.R.; Yossef, R.; Lowery, F.J.; Jafferji, M.S.; et al. mRNA Vaccine–Induced Neoantigen-Specific T Cell Immunity in Patients with Gastrointestinal Cancer. J. Clin. Investig. 2020 ,130, 5976–5988. [CrossRef] [PubMed] 110. Palmer, C.D.; Rappaport, A.R.; Davis, M.J.; Hart, M.G.; Scallan, C.D.; Hong, S.-J.; Gitlin, L.; Kraemer, L.D.; Kounlavouth, S.; Yang, A.; et al. Individualized, Heterologous Chimpanzee Adenovirus and Self-Amplifying mRNA Neoantigen Vaccine for Advanced Metastatic Solid Tumors: Phase 1 Trial Interim Results. Nat.